Education
Timely Topics in Transplantation Webinar Series
September 27, 2017
Polling questions and answers are available for download here.
Speaker: Massimo Mangiola, PhD • University of Pittsburgh Medical Center
Moderator: Julie Yabu, MD • UCLA
After participating in this webinar, the learner will be able to:
- Describe epitopes in the context of transplantation.
- Discuss the importance of epitopes in HLA compatiblity and optimizing graft outcome.
- Summarize how to potentially use "epitope tools" in HLA antibody analysis and matching of donors and recipients pairs.
June 21, 2016
Speaker: Robert Ettenger, MD • UCLA Center for Health Science
Moderator: Vikas Dharnidharka, MD • Washington University
After participating in this webinar, the learner will be able to:
- Understand the measures that can be taken before, during and after the first transplant to promote the success of the second transplant
- Identify the appropriate immunological, psychological,and technical steps that should be taken to help assure an optimal outcome
- Describe the peri- and post-transplant care, including immunosuppression, that are necessary to obtain the best results
December 12, 2016
Speaker: Minnie Sarwal, MD, PhD, MRCP, DCH, FRCP • University of California San Francisco
Moderator: Julie Yabu, MD • Stanford University
After participating in this webinar, the learner will be able to:
- Identify potential biomarkers and assays for diagnosis for rejection and graft injury
- Describe the integration of bioinformatics and datasets in transplantation
- Design a strategy to prospectively manage transplant patients using biomarkers to preserve organ function
Moderator: Julie Yabu, MD
November 04, 2014
Gena Boyle, MPA • UNOS
Richard Formica, MD • Yale University
Moderated by Nicole Turgeon, MD • Emory University
Free to AST members: $25 fee is waived upon logging in during the checkout process.
The new kidney allocation system is being implemented on December 4, 2014. Is your transplant program, OPO, and/or histocompatibility laboratory ready? During this webinar, the presenters will walk through the six major elements of the new kidney allocation system. For each element, the presenters will use screen shots and other illustrations to provide information on:
- The essential preparations that transplant programs, histocompatibility laboratories, and OPOs need to take to prepare for implementation
- How the UNOS computer system is currently programmed to assist transplant programs with preparing their list for December 4
- How the new system will capture and use these new data elements
- Helpful hints for complying with the new policy
- Answers to frequently asked questions
After participating in this webinar, the learner will be able to:
- Describe the impact of upcoming policy and system changes related to the new kidney allocation system for patients and the transplant centers.
- Utilize tools and resources provided by the OPTN to prepare for system implementation for patients and the transplant centers.
- Identify methods for compliance with the new kidney allocation policies for transplant centers.
Free to AST members: $25 fee is waived upon logging in during the checkout process.
The new kidney allocation system is being implemented on December 4, 2014. Is your transplant program, OPO, and/or histocompatibility laboratory ready? During this webinar, the presenters will walk through the six major elements of the new kidney allocation system. For each element, the presenters will use screen shots and other illustrations to provide information on:
- The essential preparations that transplant programs, histocompatibility laboratories, and OPOs need to take to prepare for implementation
- How the UNOS computer system is currently programmed to assist transplant programs with preparing their list for December 4
- How the new system will capture and use these new data elements
- Helpful hints for complying with the new policy
- Answers to frequently asked questions
After participating in this webinar, the learner will be able to:
- Describe the impact of upcoming policy and system changes related to the new kidney allocation system for patients and the transplant centers.
- Utilize tools and resources provided by the OPTN to prepare for system implementation for patients and the transplant centers.
- Identify methods for compliance with the new kidney allocation policies for transplant centers.
November 17, 2016
Speaker: Stephanie Pouch, MD • The Ohio State University Medical Center
Moderator: Shirish Huprikar, MD • Icahn School of Medicine at Mount Sinai
Multidrug-resistant organisms (MDROs) pose a particular threat to solid organ transplant recipients. Infections due to these pathogens are associated with significant morbidity and mortality, and current therapeutic options are limited.
After participating in this webinar, the learner will be able to:
- Describe the epidemiology and outcomes of select MDRO infections in solid organ transplant recipients.
- Describe an approach to the use of organs from donors colonized or infected with CRE.
- Discuss the role of infection control and antimicrobial stewardship in curtailing the spread of MDROs in solid organ transplant recipients.
October 21, 2014
Christian Oberkofler, MD • University Hospital Zurich
Thomas Mueller, MD, PhD • University Hospital Zurich
Free to AST members: $25 fee is waived upon logging in during the checkout process.
Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.
After participating in this webinar, the learner will be able to:
- Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
- Discuss living donor safety in respect to current publications and concerns
- Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation
Free to AST members: $25 fee is waived upon logging in during the checkout process.
Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.
After participating in this webinar, the learner will be able to:
- Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
- Discuss living donor safety in respect to current publications and concerns
- Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation
November 15, 2016
Speaker: Jignesh Patel, MD • Cedars-Sinai Heart Institute
Moderator: Monica Colvin, MD, MS • University of Michigan
The presence of donor specific antibodies predisposes the thoracic allograft to the risk of antibody mediated rejection, chronic graft dysfunction and increased mortality. Optimal outcomes depend upon a comprehensive understanding of the significance of circulating antibodies after transplantation. What are the best strategies for defining deleterious antibodies, what are the current available therapies to address these and how effective are they?
After participating in this webinar, the learner will be able to:
- Identify the significance of circulating antibodies in patients awaiting thoracic transplantation or in patients with development of de novo antibodies after transplantation.
- Order appropriate tests to detect relevant donor specific antibodies.
- Design rational therapies for the treatment of post-thoracic transplant circulating antibodies.
May 21, 2014
Read Q&A that wasn't answered during the webinar
Free to AST members: $25 fee is waived upon logging in during the checkout process.
Explore the relevance of HLA testing before and after transplant in solid organ transplantation. At the end of this webinar, participants will be able to:
- Understand the enhanced methods of HLA typing and antibody detection now available before transplant
- Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
- Appreciate the limitations of HLA testing and the importance of context in interpretation
Explore the relevance of HLA testing before and after transplant in solid organ transplantation.
At the end of this webinar, participants will be able to:
- Understand the enhanced methods of HLA typing and antibody detection now available before transplant
- Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
- Appreciate the limitations of HLA testing and the importance of context in interpretation
October 18, 2016
- Understand the use and limitations of solid phase assays in identifying anti-HLA antibodies
- Describe the natural history and significance of DSA development post-transplant
- Discuss novel tools to improve specificity of solid phase assays
April 23, 2014
Read Q&A that was not answered during the webinar
Free to AST members: $25 fee is waived upon logging in during the checkout process.
Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:
- A brief overview of risks of living kidney donation known to date
- Discussion of the study design, methods and statistics in the manuscripts
- Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information
Links to manuscripts:
- Abstract for Risk of End-Stage Renal Disease Following Live Kidney Donation (JAMA subscription required to view full article)
- Long-term Risks for Kidney Donors (Kidney International)
Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:
- A brief overview of risks of living kidney donation known to date
- Discussion of the study design, methods and statistics in the manuscripts
- Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information